191 related articles for article (PubMed ID: 27448537)
1. Drug-coated balloon for recurrent in-stent restenosis treatment: A suitable strategy.
Piraino D; Buccheri D; Cimino G; Andolina G
Int J Cardiol; 2016 Oct; 221():1084-6. PubMed ID: 27448537
[No Abstract] [Full Text] [Related]
2. First reported use of drug-coated balloon for bioresorbable in-scaffold restenosis.
Latini RA; Buccheri D; Cortese B
Catheter Cardiovasc Interv; 2017 Mar; 89(4):676-678. PubMed ID: 27649683
[TBL] [Abstract][Full Text] [Related]
3. Treatment of drug-eluting stents in-stent restenosis with paclitaxel-coated balloon angioplasty: Insights from the French "real-world" prospective GARO Registry.
Auffret V; Berland J; Barragan P; Waliszewski M; Bonello L; Delarche N; Furber A; Albert F; Carrié D; Eltchaninoff H; Pansieri M; Schneeberger M; Piot C; Marcollet P; Bedossa M
Int J Cardiol; 2016 Jan; 203():690-6. PubMed ID: 26583844
[TBL] [Abstract][Full Text] [Related]
4. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study.
Adriaenssens T; Dens J; Ughi G; Coosemans M; Onsea K; Dubois C; Sinnaeve P; Vrolix M; Desmet W
EuroIntervention; 2011 May; 7 Suppl K():K100-5. PubMed ID: 22027717
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxcel-coated balloon plus bare metal stent vs. sirolimus-eluting stent in de novo lesions: an IVUS study.
Fischer D; Scheller B; Schäfer A; Klein G; Böhm M; Clever Y; Cremers B
EuroIntervention; 2012 Aug; 8(4):450-5. PubMed ID: 22917728
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis.
Liu S; Worme M; Yanagawa B; Kumar N; Buller CE; Cheema AN; Bagai A
J Invasive Cardiol; 2018 Oct; 30(10):360-366. PubMed ID: 30108189
[TBL] [Abstract][Full Text] [Related]
8. Stent coverage and neointimal proliferation in bare metal stents postdilated with a Paclitaxel-eluting balloon versus everolimus-eluting stents: prospective randomized study using optical coherence tomography at 6-month follow-up.
Poerner TC; Otto S; Gassdorf J; Nitsche K; Janiak F; Scheller B; Goebel B; Jung C; Figulla HR
Circ Cardiovasc Interv; 2014 Dec; 7(6):760-7. PubMed ID: 25371536
[TBL] [Abstract][Full Text] [Related]
9. A prospective, multicenter, randomized trial of paclitaxel-coated balloon versus paclitaxel-eluting stent for the treatment of drug-eluting stent in-stent restenosis: results from the PEPCAD China ISR trial.
Xu B; Gao R; Wang J; Yang Y; Chen S; Liu B; Chen F; Li Z; Han Y; Fu G; Zhao Y; Ge J;
JACC Cardiovasc Interv; 2014 Feb; 7(2):204-211. PubMed ID: 24556098
[TBL] [Abstract][Full Text] [Related]
10. The Absorb Limits.
Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
[TBL] [Abstract][Full Text] [Related]
11. Late Restenosis After Paclitaxel-Coated Balloon Angioplasty Occurs in Patients With Drug-Eluting Stent Restenosis.
Habara S; Kadota K; Shimada T; Ohya M; Amano H; Izawa Y; Kubo S; Hyodo Y; Otsuru S; Hasegawa D; Tada T; Tanaka H; Fuku Y; Goto T; Mitsudo K
J Am Coll Cardiol; 2015 Jul; 66(1):14-22. PubMed ID: 26139053
[TBL] [Abstract][Full Text] [Related]
12. Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials.
Lee JM; Park J; Kang J; Jeon KH; Jung JH; Lee SE; Han JK; Kim HL; Yang HM; Park KW; Kang HJ; Koo BK; Kim HS
JACC Cardiovasc Interv; 2015 Mar; 8(3):382-394. PubMed ID: 25703886
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
[TBL] [Abstract][Full Text] [Related]
14. Treatment for in-stent restenosis requiring rotational atherectomy.
Hachinohe D; Kashima Y; Hirata K; Kanno D; Kobayashi K; Kaneko U; Sugie T; Tadano Y; Watanabe T; Shitan H; Haraguchi T; Enomoto M; Sato K; Fujita T
J Interv Cardiol; 2018 Dec; 31(6):747-754. PubMed ID: 30175429
[TBL] [Abstract][Full Text] [Related]
15. Association between tissue characteristics assessed with optical coherence tomography and mid-term results after percutaneous coronary intervention for in-stent restenosis lesions: a comparison between balloon angioplasty, paclitaxel-coated balloon dilatation, and drug-eluting stent implantation.
Tada T; Kadota K; Hosogi S; Miyake K; Ohya M; Amano H; Izawa Y; Kanazawa T; Kubo S; Ichinohe T; Hyoudou Y; Hayakawa Y; Sabbah MM; Otsuru S; Hasegawa D; Habara S; Tanaka H; Fuku Y; Katoh H; Goto T; Mitsudo K
Eur Heart J Cardiovasc Imaging; 2015 Oct; 16(10):1101-11. PubMed ID: 25762559
[TBL] [Abstract][Full Text] [Related]
16. Twenty-four months of follow-up of a "biodegradable" model for coronary artery bifurcation management. Insights from optical coherence tomography of a new interventional strategy.
Buccheri D; Cortese B
Int J Cardiol; 2016 Nov; 222():37-38. PubMed ID: 27448703
[No Abstract] [Full Text] [Related]
17. Effect of drug-coated balloon angioplasty on in-stent restenotic coronary lesions analyzed with optical coherence tomography and serial coronary artery angioscopy.
Akutsu N; Ogaku A; Koyama Y; Fujito H; Ebuchi Y; Migita S; Morikawa T; Tamaki T; Mineki T; Kougo T; Kojima K; Iida K; Murata N; Nishida T; Oshima T; Sudo M; Kitano D; Haruta H; Fukamachi D; Takayama T; Hiro T; Hirayama A; Okumura Y
Heart Vessels; 2019 Dec; 34(12):1925-1935. PubMed ID: 31203393
[TBL] [Abstract][Full Text] [Related]
18. Treatment of in-stent restenosis with bioresorbable vascular scaffolds: optical coherence tomography insights.
Rivero F; Bastante T; Cuesta J; Benedicto A; Restrepo JA; Alfonso F
Can J Cardiol; 2015 Mar; 31(3):255-9. PubMed ID: 25660152
[TBL] [Abstract][Full Text] [Related]
19. Left main "Culotte in Culotte" to manage a trapped broken balloon.
Ancona MB; Giannini F; Jabbour RJ; Tanaka A; Regazzoli D; Mangieri A; Carlino M; Colombo A
Int J Cardiol; 2016 Oct; 221():347-9. PubMed ID: 27404703
[No Abstract] [Full Text] [Related]
20. A case of subacute stent thrombosis after drug-coated balloon coronary angioplasty for in-stent restenosis under single anti-platelet therapy.
Kagawa Y; Shiode N; Kawase T; Tamekiyo H; Okimoto T; Hayashi Y
Cardiovasc Interv Ther; 2017 Apr; 32(2):170-173. PubMed ID: 26979600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
